Foresite

Gilead, Foresite back biotech developer of COVID-19 pill in latest SPAC deal
BioPharma Dive
Wed, 06/30/21 - 12:11 am
antivirals
COVID-19
Gilead Sciences
Foresite
Pardes Biosciences